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ABSTRACT
Gastrointestinal manifestations are common in systemic lupus erythematosus (SLE). Although the relationship 
between SLE with ulcerative colitis (UC) rarely obtained, SLE patients with gastrointestinal manifestations should 
preferably be evaluated for the possibility of an inflammatory bowel disease (IBD). UC prognosis associated 
with SLE is usually good, whereas by proper diagnosis and management, the clinical output and a good life 
expectancy of patients will be obtained
A young female, 17 years old, who had previously been diagnosed with SLE for 5 years, came with complaints 
of abdominal pain and chronic diarrhea. From the results of colonoscopy and biopsy of the intestinal mucosa 
was noted that in accordance with UC. After receiving treatment for 6 days, she no longer obtained complaints 
of abdominal pain and diarrhea.
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ABSTRAK
Manifestasi gastrointestinal merupakan hal yang sering terjadi pada lupus eritematosus sistemik (LES). 
Meskipun hubungan antara LES dengan kolitis ulseratif (KU) jarang didapatkan, sebaiknya pada pasien LES 
dengan manifestasi gastrointestinal dilakukan evaluasi untuk kemungkinan adanya suatu penyakit inflamasi 
usus besar. Prognosis UC terkait LES biasanya baik, dimana dengan diagnosis dan penatalaksanaan yang tepat 
akan didapatkan keluaran klinis dan harapan hidup yang baik pada pasien.
Seorang perempuan muda berusia 17 tahun yang sebelumnya telah terdiagnosa LES selama 5 tahun, datang 
dengan keluhan nyeri perut dan diare kronik. Dari hasil pemeriksaan kolonoskopi dan biopsi mukosa usus 
didapatkan gambaran yang sesuai dengan KU. Setelah mendapat terapi selama 6 hari, tidak didapatkan lagi 
keluhan nyeri perut dan diare.
Kata kunci: lupus eritematosus sistemik, gastrointestinal, colitis ulseratif, penyakit inflamasi usus besar
INTRODUCTION
Systemic lupus erythematosus (SLE) and 
inflammatory bowel disease (IBD) are systemic diseases 
caused by abnormal immune response, depending on 
the interaction between genetic vulnerability and 
environmental factor.1 Gastrointestinal manifestation 
is commonly found in SLE. Although not as common 
as nephritis lupus, clinically SLE-associated 
gastrointestinal involvement is significant because 
most of these cases may become life-threatening if not 
being treated promptly. Anorexia, nausea, vomitting, 
dysphagia, abdominal pain, diarrhea, digestive tract 
bleeding are symptoms which happen to approximately 
50% patients with SLE.2 Persistent diarrhea occuring 
due to ulcerative colitis (UC), which is also one of the 
IBDs, is reported in several studies to be associated 
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with SLE.3 UC also has strong relation with the 
occurrence of autoimmune diseases.4 Dubois et al 
reported SLE cases with diarrhea as much as 5.9%,5 
Fries et al stated 25%,6 Jessar et al 13%,7 while Harvey 
et al 8%.8 This case report will discuss about the 
diagnosis and management of SLE and UC.
CASE ILLUSTRATION
A 17 year old female came with the complaint of 
watery stool since 2 days before hospital admission 
with the frequency of 5-8 times per day, with mucous 
in the faeces. Patient also complained of lethargic and 
looked pale. Pain was felt in the lower abdominal area 
every time before diarrhea and subsided after diarrhea. 
Appetite was decreased due to stomach fullness. 
Seventeen days earlier, patient was also admitted to 
the hospital with similar symptoms. Patient had been 
diagnosed with SLE since 2007, routinely visited the 
Internal Medicine Outpatient Clinic, Saiful Anwar 
Hospital for check-up and had received therapies 
azathioprine 50 mg twice daily, metilprednisolone with 
the dose of 8 mg twice daily. Besides, patient had also 
received captopril 6.25 mg thrice daily and calcium 
supplement once daily.
From physical examination, it was found that 
Glasgow coma scale (GCS) 456, blood pressure 90/60 
mmHg, axilla temperature 36.5oC, heart rate 88 bpm, 
respiratory rate 24 times per minute, patient looked 
moderately ill, underweight and moonface. Body 
weight 33 kg, height 156 cm, BMI 13.56 kg/m2. From 
head examination, there was anemic conjunctiva, 
cloudy in bilateral ocular lenses and malar rash. From 
chest examination, it was found that right heart border 
was in right SL and left heart border in 5th ICS left 
MCL, ictus cordis was seen, palpable at 5th ICS left 
MCL. Lungs examination was within normal limits. 
From inspection of the abdomen, we found that there 
was 8 cm scar in the right lower region, increased 
bowel sound. Extremities examination was within 
normal limits. Urine production was 62 mL/hour. 
Laboratory examination revealed hemoglobin (Hb) 
8.7 g/dL, leukocyte 6,900/uL, lymphocyte 500/uL, 
thrombocyte 300,000/uL, erythrocyte sedimentation 
rate (ESR) 68 mm/hour, aspartate transaminase (AST) 
29 U/L, alanine transaminase (ALT) 12 U/L, random 
blood glucose 113 mg/dL, albumin 2.20 g/dL, ureum 
41.2 mg/dL, creatinine 0.9 mg/dL, serum electrolyte 
natrium 136 mmol/L, kalium 4.5 mmol/L, chloride 109 
mmol/L. Plasma mass density ≤ 1.024. Urinalysis mass 
density 1.020, pH 6.5, protein albumin +1, erythrocyte 
3+, 10x = epithel 1-2/SPF, 40x = erythrocyte 40-50/
HPF, leukocyte 2-4/HPF. Complete faecal analysis, 
white in colour, soft consistency, epithel 1+/HPF; 
leucocyte 0-2, cyte 2-4, Entamoeba hystolitica cyst was 
identified. Faecal culture results showed Enterobacter 
gergoviae strongly sensitive to colistin, cotrimoxazole, 
amoxycillin and clavulanic acid, ceftriaxone, and 
gentamycin antibiotics.
Colonoscopy results revealed many ulcers from the 
rectum until the caecum with various shapes and sizes, 
then biopsy from several locations was performed. 
Conclusion drawn was suspect of ulcerative colitis. 
From biopsy of 4 colon mucosa specimens, we found 
microscopic appearance with broad erosion, destruction 
of crypt, cryptitis, lamina propria, infiltration of plasma 
cells, lymphocytes and neutrophils, a few eosinophil 
cells, glands experienced mild degree of dysplasia. 
Some glands showed proliferative, normal blood 
vessels, muscular mucosa was observed, lymphoid 
folicles were not found, very few macrophage cells, 
malignant cells were not found. There were also group 
of plasma cells, lymphocytes and neutrophils with a 
conclusion of ulcerative colitis.
Figure 1. Colonoscopy results showed multiple ulcer and 
hyperemic mucosa
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occurrence of SLE.11 Estimated prevalence of UC in 
SLE patients is ± 0.4% and Crohn's disease is even 
less than that.2,12,13 It is also reported by Snook et al in 
a study of 1,200 IBD patients, 6.6% patients with UC 
had at least another one autoimmune abnormality.12
Coexistence of SLE and IBD is difficult to 
diagnose because both diseases have several similar 
gastrointestinal symptoms and some drugs used to 
treat IBD may cause drug-induced lupus.2 Diagnosing 
IBD in SLE is quite challenging due to several factors. 
First, almost 50% SLE patients have gastrointestinal 
symptoms, the most common is stomachache.8 Second, 
UC may happen before or after the diagnosis of 
SLE.2 In most cases, diagnosis of SLE is confirmed 
before IBD. The first disease is usually inactive in 
the manifestation of the second disease. Patient with 
both processes tends to experience less photosensitive, 
serositis, and neurological disturbance, and in general 
has relative good prognosis from both SLE and IBD.2,13 
In this patient, diagnosis of SLE was confirmed before 
colitis was diagnosed. This showed that UC occurred in 
idiopathic SLE. In a case of chronic diarrhea, it may be 
found two or more etiologies and or pathophysiology 
of diseases. Colonoscopy is not routinely performed 
in every chronic diarrhea cases, however it helps to 
confirm the main diagnosis in pathology anatomy 
through intestinal mucosa biopsy.14 In this patient, 
colonoscopy results revealed suspect of UC and 
was supported with the intestinal mucosa biopsy 
results; there was broad erosion, destruction of crypt, 
cryptitis, lamina propria, infiltration of plasma cells, 
lymphocytes and neutrophils, few eosinophil cells, 
glands experienced mild degree of dysplasia. Some 
glands showed proliferative, normal blood vessels, 
muscular mucous was observed, no lymphoid folicles 
were found, very few macrophage cells, no malignant 
cells were found. There was also groups of plasma 
cells, lymphocytes, and neutrophils.
Hoffman et al in their review regarding 
gastrointestinal manifestations in SLE found that there 
was no clear border in idiopathic cases of SLE which 
was associated with UC.15 Some differences between 
sulphasalazine-induced SLE (in UC patients) and 
incidence of UC in idiopathic SLE are the presence of 
low amount of complements (in drug-induced lupus, 
complement value is generally normal) and negative 
dsDNA.4 Besides, idiopathic SLE is accompanied 
with the presence of various types of autoantibodies, 
such as: collagen-like reseptor (CLR) to C1q which 
present in approximately 47% patients with SLE, 
anticardiolipin antibody (in 10-30% SLE patients), 
Figure 2. Macroscopic appearance of intestinal mucosa biopsy 
which was performed in several places
Figure 3. Macroscopic and microscopic pictures of intestinal 
mucosa biopsy showed erosion and crypt destruction with 
inflammatory cells infiltration
Problem list in this patient include chronic 
inflammatory diarrhea caused by IBD, SLE on 
treatment, immature cataract one day care surgery 
(ODS), and malnutrition. Patient received therapy; 
1900 kcal per day low fiber diet, intravenous 
injection of ceftriaxone 1 gram twice daily, orally 
administered medicine metilprednisolon 8 mg twice 
daily, azathioprine 50 mg twice daily, captopril 6.25 
mg thrice daily, and attapulgite 2 tablets per diarrhea, 
maximal 12 tablets per day. Therapy response after 
6 days with those medicines mentioned above was 
evaluated, patient's general condition ameliorated, no 
more complaint of stomachache or diarrhea. 
DISCUSSION
SLE may manifest in the entire gastrointestinal 
tract.9 SLE and UC are chronic autoimmune diseases 
with the characteristic of relapse and remission 
episodes.1,10 The presence of SLE with inflammatory 
gastrointestinal disease is a frequently questioned 
phenomenon, but is rarely associated.9 The relationship 
between SLE and UC is very rare and has only been 
documented in several case reports. Dubois et al found 
2 cases from 520 patients.5 Other studies reported 
the association in 2 cases from 464 patients and 
other literature studies stated most colitis preceed the 
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anti Ro, anti-La antibody, human leukocyte antigen 
(HLA) DR3 are associated with idiopathic SLE, while 
HLA DR4 may be found in drug induced lupus.16 In this 
patient, those autoantibodies were not examined due 
to financial reason and limitations in the examination 
procedure.
Severity degree of UC is based on patient's 
symptoms and to the area of colitis, not to the 
severity degree of inflammation histologically. 
Based on Montreal classification, this patient was 
included in severe degree of UC, based on defecation 
frequency > 6 times, Hb < 10.5 g/dL, and ESR > 
30 mm/hour.17 Current therapies to treat patients 
with UC include aminosalicylates (5-ASA), steroid, 
immunosuppresants, and biological agent (infliximab, 
tocolizumab).13 Antibiotic is also adviced in severe 
degree of UC if an infection is found.17 In this patient, 
therapies given were appropriate to the routine SLE 
therapy, which were: steroid and azathioprine. Besides, 
antibiotic ceftriaxone, which was appropriate with the 
culture results, was added to eradicate infection.
If a patient is diagnosed with SLE and initiated by 
gastrointestinal symptoms, including stomachache and 
diarrhea, particularly if not associated with clinical 
symptoms of recurrent SLE, it is wise to think about 
IBD.17 Prognosis of SLE associated IBD is usually 
good.2 With prompt diagnosis and management, 
patient's good clinical outcome and life expectation 
will be obtained.
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